Cargando…

Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS

The wide-spread use of the anti-complement component 5 monoclonal antibody (moAb) eculizumab has greatly reduced the incidence of relapsing atypical hemolytic uremic syndrome (aHUS) after kidney transplantation (KT). However, the optimal management of aHUS transplant candidates with anti-Complement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Favi, Evaldo, Molinari, Paolo, Alfieri, Carlo, Castellano, Giuseppe, Ferraresso, Mariano, Cresseri, Donata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795842/ https://www.ncbi.nlm.nih.gov/pubmed/36591301 http://dx.doi.org/10.3389/fimmu.2022.1073808

Ejemplares similares

Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS
por: Cheung, Chee Kay, et al.
Publicado: (2019)

Prevalence and Risk Factors of Abnormal Glucose Metabolism and New-Onset Diabetes Mellitus after Kidney Transplantation: A Single-Center Retrospective Observational Cohort Study
por: Alfieri, Carlo, et al.
Publicado: (2022)

Epidemiology, Clinical Characteristics, Diagnostic Work Up, and Treatment Options of Leishmania Infection in Kidney Transplant Recipients: A Systematic Review
por: Favi, Evaldo, et al.
Publicado: (2022)

Impact of Donor Age on Clinical Outcomes of Primary Single Kidney Transplantation From Maastricht Category-III Donors After Circulatory Death
por: Favi, Evaldo, et al.
Publicado: (2018)

Remission of aHUS neurological damage with eculizumab
por: Ávila, Ana, et al.
Publicado: (2015)

Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study
por: Molinari, Paolo, et al.
Publicado: (2023)

New-Onset Diabetes after Kidney Transplantation
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Eculizumab and aHUS: Spotlight on Patient-Centered Care
por: Rafat, Cédric, et al.
Publicado: (2020)

Cytomegalovirus Disease in Renal Transplanted Patients: Prevalence, Determining Factors, and Influence on Graft and Patients Outcomes
por: Alfieri, Carlo Maria, et al.
Publicado: (2021)

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
por: Pape, Lars, et al.
Publicado: (2016)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
por: Umscheid, Jacob H., et al.
Publicado: (2021)

Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study
por: Alfieri, Carlo, et al.
Publicado: (2021)

Viral Genomic Characterization and Replication Pattern of Human Polyomaviruses in Kidney Transplant Recipients
por: Signorini, Lucia, et al.
Publicado: (2020)

Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016)

Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS—Case Report
por: Lokki, A. Inkeri, et al.
Publicado: (2020)

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
por: Bouwmeester, Romy N., et al.
Publicado: (2021)

Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab
por: Kelen, Dorottya, et al.
Publicado: (2021)

Outcomes of Patients Receiving a Kidney Transplant or Remaining on the Transplant Waiting List at the Epicentre of the COVID-19 Pandemic in Europe: An Observational Comparative Study
por: Perego, Marta, et al.
Publicado: (2022)

Trends of characteristics and outcomes of donors and recipients of deceased donor liver transplantation in the United States: 1990 to 2013
por: Ayloo, Subhashini, et al.
Publicado: (2018)

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013)

Clinical Relapses of Atypical HUS on Eculizumab: Clinical Gap for Monitoring and Individualised Therapy
por: Teoh, Chia Wei, et al.
Publicado: (2018)

Allograft Vesicoureteral Reflux after Kidney Transplantation
por: Brescacin, Alessandra, et al.
Publicado: (2022)

Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
por: McBride, Helen J., et al.
Publicado: (2023)

Multidisciplinary management of complicated bilateral renal artery aneurysm in a woman of childbearing age
por: Favi, Evaldo, et al.
Publicado: (2018)

Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing
por: Benoit, Stefanie W., et al.
Publicado: (2022)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

UPPER MIDLINE INCISION IN RECIPIENTS OF DECEASED-DONORS LIVER TRANSPLANTATION
por: da FONSECA-NETO, Olival Cirilo Lucena, et al.
Publicado: (2018)

Treatment options for localised renal cell carcinoma of the transplanted kidney
por: Motta, Gloria, et al.
Publicado: (2020)

Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects
por: Molinari, Paolo, et al.
Publicado: (2022)

Peritoneal Dialysis for Potential Kidney Transplant Recipients: Pride or Prejudice?
por: Nardelli, Luca, et al.
Publicado: (2022)

Case report: Short-term eculizumab use in atypical HUS associated with Lemierre's syndrome and post-infectious glomerulonephritis
por: Sadiq, Sanober, et al.
Publicado: (2023)

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY
por: Trotman, Judith, et al.
Publicado: (2023)

Association of Deceased Donor Acute Kidney Injury With Recipient Graft Survival
por: Liu, Caroline, et al.
Publicado: (2020)

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
por: Ohanian, Maro, et al.
Publicado: (2011)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality
por: Ardissino, Gianluigi, et al.
Publicado: (2021)

Post-reperfusion bronchospasm in a deceased donor liver transplant recipient: An enigma
por: Bharath, Kiran, et al.
Publicado: (2017)

Early Graft Function in Deceased Donor Renal Recipients: Role of N-Acetylcysteine
por: Modarresi, Atieh, et al.
Publicado: (2020)

Evaluating Potential Deceased Donor Renal Transplant Recipients for Asymptomatic COVID-19
por: Ho, Quan Yao, et al.
Publicado: (2020)

Scedosporium Infection in Recipients of Kidney Transplants from Deceased Near-Drowning Donor
por: Choudhary, Devprakash, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pq3u860mr7prq3tb793je05hif